Riskpilot← Back to searchSign inGet full accessPROVIDA MEDICAL AS
ASActiveOrg 918550100Mustads Vei 10, 0283 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20170 employeeswww.providamed.com
Revenue 2024
NOK 22K
-40% vs 2023
EBITDA margin
-907.7%
+70% vs 2023
Equity ratio
-864.4%
Financial strength
Net profit 2024
NOK -241K
+65% vs 2023
| Revenue | NOK 22K | -40% |
| EBITDA | NOK -203K | +70% |
| Net profit | NOK -241K | +65% |
| Total assets | NOK 59K | +8% |
| Equity | NOK -512K | -89% |
| Employees | 0 | — |
Legal name
PROVIDA MEDICAL AS
Org number
918550100
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13. februar 2017
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Handel, produksjon, utvikling, distribusjon og markedsføring av produkter og tjenester innen helse- og bioteknologi, deltakelse i andre selskaper, samt å yte administrative, operasjonelle, finansielle, forretningsmessige, forskningsmessige eller industrielle tjenester til enhver tredjepart, aksjeeier, datterselskap, tilknyttet selskap, herunder også lån, forskudd og garantier, samt annen virksomhet som hermed er forbundet.
Address
Mustads Vei 10, 0283 Oslo
Website
www.providamed.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 364 | 11 491 | 24 961 | 37 | 22 |
| Staff expenses | −0 | −2 | −10 | −0 | −0 |
| EBITDA | 336 | 336 | 30 | −680 | −203 |
| Depreciation & amort. | −0 | −0 | −1 | −6 | −10 |
| EBIT | 336 | 336 | 29 | −686 | −213 |
| Net financials | −1 | −21 | −48 | 2 | −29 |
| Profit before tax | 335 | 316 | −20 | −684 | −241 |
| Tax | 68 | 69 | −0 | −0 | −0 |
| Net profit | 267 | 246 | −20 | −684 | −241 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 627 | 13 505 | 589 | 55 | 59 |
| Equity | 270 | 433 | 413 | −271 | −512 |
| Long-term debt | 0 | 0 | 0 | 0 | 384 |
| Short-term debt | 356 | 13 071 | 176 | 325 | 187 |
| Total debt | 356 | 13 071 | 176 | 325 | 571 |
EBITDA margin
-907.7%
This company
15.8%
Market median
-5845% vs market
20202024
Equity ratio
-864.4%
This company
38.2%
Market median
-2363% vs market
20202024
Return on equity
-24147400.0%
This company
18.4%
Market median
-131235970% vs market
20202024
Net profit margin
-1081.1%
This company
8.1%
Market median
-13447% vs market
20202024
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
20202024
Debt / equity
1.12×
This company
0.62×
Market median
-81% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JS Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Axcellera Holding As
PROVIDA MEDICAL AS Board members of PROVIDA MEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Simonnæs | Chief Executive Officer | 0 companies |
| Yngve Kristiansen | Chairman | 0 companies |